DALLAS, March 10, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring BioElectronics Corp. (Pink Sheets:BIEL). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
The full report is available at: http://www.stockpreacher.com/n/BIEL
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/StockPreacher
BioElectronics Corp. (BIEL) designs, develops and markets a variety of drug-free, anti-inflammatory patches for a range of medical indications. The Company's patch products, which are marketed under the name ActiPatch Therapy, deliver pulsed electromagnetic field therapy, an anti-inflammatory and pain relief therapy.
Message Board Search for BIEL: http://www.boardcentral.com/boards/BIEL
In the report, the analyst notes:
"BIEL last week announced a major upgrade to its ActiPatch Therapy® product line. The upgrade consists of a new methodology for attaching the Company's patented technology to the human body. Beginning effectively with the next product manufacturing run, all ActiPatch Therapy® products will utilize a new type of flexible and highly durable elastic strap with Velcro ends that will enable users to place this award winning technology directly over the site of their pain or inflammation. BIEL plans to formally introduce its new back pain belt over the coming next few months, with shipments to international distributors beginning shortly thereafter.
"In 2006, the Company and the Lahey Clinic jointly announced a three-year program to study the effects of ActiPatch Therapy on a variety of soft tissue injuries and related medical conditions. The internationally renowned Lahey Clinic of Boston, whose faculty is affiliated with the Medical Schools of Harvard and Tufts, has committed to initiating a number of double-blind clinical studies on ActiPatch Therapy in the areas of plastic surgery, orthopedics and chronic wound care. Results from these clinical trials will be submitted to the U.S. Food and Drug Administration (the FDA) for expanded indications for the use of ActiPatch Therapy."
To read the entire report visit: http://www.stockpreacher.com/n/BIEL
See what investors are saying about BIEL at penny stock forum
StockPreacher.com is a small-cap research and investment commentary provider. StockPreacher.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on StockPreacher, please visit: http://www.stockpreacher.com
StockPreacher.com Disclosure
StockPreacher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. StockPreacher.com is a Web site wholly owned by BlueWave Advisors, LLC. StockPreacher.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, StockPreacher.com, for complete risks and disclosures.